102260.KS KSC
Dongsung Chemical Co., Ltd.
1W: +3.5%
1M: -0.9%
3M: +2.5%
YTD: -15.3%
1Y: -12.5%
3Y: +39.1%
5Y: +8.1%
₩3,740.00 ($2.78)
+25.00 (+0.67%)
Weekly Expected Move ±3.1%
₩3509
₩3625
₩3740
₩3855
₩3971
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$1.21T
+13.6% ▲
5Y CAGR: +7.0%
Gross Profit
$226.1B
+14.9% ▲
5Y CAGR: +6.7%
Operating Income
$111.4B
+22.4% ▲
5Y CAGR: +11.4%
Net Income
$33.3B
-26.0% ▼
5Y CAGR: +37.9%
EPS (Diluted)
$672.00
-26.6% ▼
5Y CAGR: +34.8%
EBITDA
$147.0B
+23.2% ▲
5Y CAGR: +10.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $926.0B | $1.14T | $1.12T | $1.07T | $1.21T |
| YoY Growth | +7.2% | +23.1% | -1.9% | -4.6% | +13.6% |
| Cost of Revenue | $788.8B | $994.6B | $944.3B | $869.5B | $985.5B |
| Gross Profit | $136.0B | $145.6B | $173.7B | $196.8B | $226.1B |
| Gross Margin | 14.7% | 12.8% | 15.5% | 18.5% | 18.7% |
| R&D Expenses | $1.8B | $2.3B | $2.5B | $4.0B | $6.0B |
| SG&A Expenses | $37.6B | $40.9B | $77.2B | $36.3B | $114.0B |
| Operating Expenses | $87.5B | $90.1B | $79.8B | $105.8B | $114.0B |
| Operating Income | $43.6B | $55.4B | $74.1B | $91.0B | $111.4B |
| Operating Margin | 4.7% | 4.9% | 6.6% | 8.5% | 9.2% |
| Interest Expense | $5.4B | $5.4B | $8.6B | $4.6B | $5.4B |
| Income Before Tax | $53.6B | $55.8B | $68.5B | $89.0B | $98.2B |
| Tax Expense | $12.2B | $8.9B | $9.8B | $27.8B | $22.6B |
| Net Income | $17.9B | $35.0B | $33.5B | $45.0B | $33.3B |
| Net Margin | 1.9% | 3.1% | 3.0% | 4.2% | 2.7% |
| EPS (Diluted) | $362.38 | $700.99 | $675.25 | $916.00 | $672.00 |
| EBITDA | $89.6B | $84.6B | $105.0B | $119.3B | $147.0B |
| Shares Outstanding | 49M | 50M | 49M | 49M | 49M |